TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Total Liabilities

Annual figures by period end, from SEC filings.

129.76M CNY
As of 2025-12-31
160.62M CNY2023-12-31: 160.62M CNY2024-12-31: 140.71M CNY2025-12-31: 129.76M CNY129.76M CNY
2023-12-31 Total Liabilities (CNY) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31129.76M CNY-7.8%2026-04-28, Balance as of period end
2024-12-31140.71M CNY-12.4%2026-04-28, Balance as of period end
2023-12-31160.62M CNYn/a2025-07-03, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-31129.76M CNY-7.8%
Yatsen Holding Ltd (YSG)2025-12-31846.34M CNY-2.5%

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗